U
AKAO

UBS’s Achaogen Inc AKAO Stock Holding History

UBS’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$9K Buy
+1,036
New +$10.6K ﹤0.01% 8975
2014
Q2 		– Sell
-6,923
Closed -$107K – 11035
2014
Q1 		$107K Buy
+6,923
New +$120K ﹤0.01% 5896

Other funds holding AKAO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS's AKAO Position: Q3 2014 in Review

UBS opened a new position in Achaogen Inc (AKAO) in Q3 2014: 1,036 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #8975 among its holdings. This is a return to the name: UBS previously reported a position in AKAO as recently as Q1 2014.

UBS first reported a position in AKAO in Q1 2014 and has held it in 2 quarters since. The position peaked at $107K in Q1 2014. 53 funds tracked by Wall St. Rank hold AKAO as of Q3 2014.

  • UBS held 1,036 shares of Achaogen Inc worth $9K as of Q3 2014.
  • Achaogen Inc was a new UBS position in Q3 2014.
  • Achaogen Inc made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8975 holding.
  • UBS first reported a position in Achaogen Inc in Q1 2014 and has held it in 2 quarters since.
  • UBS's Achaogen Inc position peaked at $107K in Q1 2014.
  • 53 funds tracked by Wall St. Rank held Achaogen Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.